SGLT2 Inhibitors Curb AF Post-Ablation Recurrences in T2D

Retrospective, observational data from more than 13,000 US patients with type 2 diabetes and atrial fibrillation suggest that SGLT2 inhibitor treatment may cut AF recurrences post-ablation.
Medscape Medical News

source https://www.medscape.com/viewarticle/995415?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?